Should Nanobots Be Used to Treat Cancer? By: Student ID 0017404 - PowerPoint PPT Presentation

Dec 26, 2022 •207 likes •302 views

Should Nanobots Be Used to Treat Cancer? By: Student ID 0017404 Overview Three Reasons Why Nanobots Counterarguments Should Be Used to Treat Cancer Q&A Session Refutation FIRST ARGUMENT Nanobots can detect early stages of cancer cell

Should Nanobots Be Used to Treat Cancer? By: Student ID 0017404
Overview Three Reasons Why Nanobots Counterarguments Should Be Used to Treat Cancer Q&A Session Refutation
FIRST ARGUMENT Nanobots can detect early stages of cancer cell formation .
Second Argument Nanobots can diagnose and treat diabetes.
Third Argument Nanobots can perform CNS surgeries safer than traditional surgeries .
Counterargument Nanobots may have the potential to destroy other cells.
Refutation Nanobots are designed to operate on specific sites.
Nanobots can detect early stages of cancer cell formation. Nanobots can diagnose and treat SUMMARY diabetes. OF Nanobots can perform CNS surgeries TODAY’S safer than traditional surgeries. TALK Nanobots may have the potential to destroy cells. Nanobots are designed to operate on specific sites.
Questions?

Recommend

Targeting Src to treat antiestrogen resistant breast cancer breast cancer Joyce Slingerland

Targeting Src to treat antiestrogen resistant breast cancer breast cancer Joyce Slingerland Braman Family Breast Cancer Institute Sylvester Comprehensive Cancer Center U of Miami Miller School of Medicine p27- key mediator of G1 arrest

699 views • 42 slides

End Cervical Cancer: Prevent, Treat, Care UN Joint Global Programme on Cervical Cancer

End Cervical Cancer: Prevent, Treat, Care UN Joint Global Programme on Cervical Cancer Prevention and Control #cxca JOINT PROGRAMME MEMBERS PRIORITIES COUNTRY LEVEL Support countries in the design and implementation of a comprehensive

390 views • 15 slides

How I Treat Metastatic Colorectal Cancer Making Sense of the Data Axel Grothey West Cancer

How I Treat Metastatic Colorectal Cancer Making Sense of the Data Axel Grothey West Cancer Center, U Tennessee The Luxury of So Many Options . . . How Do We Personalize? Patient X Patient Y Patient Z PD-1 mAb What influences treatment

284 views • 27 slides

How to treat men with pN1 Prostate Cancer? Alberto BOSSI Dept of Radiation Oncology Research

Node Positive Prostate Cancer: How to treat men with pN1 Prostate Cancer? Alberto BOSSI Dept of Radiation Oncology Research Support Ipsen, Janssen, Sanofi Employee Gustave Roussy, Villejuif, France Consultant Astellas, Bard, Elekta, Ipsen

820 views • 44 slides

A Cancer Immunotherapy Company Harnessing the Human Immune System To Diagnose and Treat Cancer

A Cancer Immunotherapy Company Harnessing the Human Immune System To Diagnose and Treat Cancer March 2015 1 Disclaimer Forward Looking Statements THIS PRESENTATION CONTAINS FORWARD-LOOKING STATEMENTS AND PROJECTIONS. THE COMPANY MAKES NO

469 views • 26 slides

5/1/2009 Do we need biopsy to treat early inoperable lung cancer? Frank J. Lagerwaard MD PhD VU

5/1/2009 Do we need biopsy to treat early inoperable lung cancer? Frank J. Lagerwaard MD PhD VU University medical center Amsterdam, The Netherlands Perspectives in Lung Cancer, Bruxelles, 2009 VUmc Amsterdam Pathological verification of malignancy

444 views • 9 slides

Phase 2 Randomization: 1:1:1 Switch over to ARM A n=132 Treat to Niraparib Bevacizumab

ENGOT-OV24-NSGO/AVANOVA Phase 2 Randomization: 1:1:1 Switch over to ARM A n=132 Treat to Niraparib Bevacizumab PD/toxicity 300mg OD d1-21 15mg/kg q3w Platinum- sensitive Ovarian Cancer ARM B Treat to Randomize Niraparib

319 views • 7 slides

Asymptomatic Metastatic Castrate Resistant Prostate Cancer Miki Haifler, MD, M.Sc Urologic

Asymptomatic Metastatic Castrate Resistant Prostate Cancer Miki Haifler, MD, M.Sc Urologic Oncology Department of Urology Shamir (Assaf Haroffeh) Medical Center Sackler Faculty of Medicine Tel-Aviv University To Treat or Not to Treat? And

649 views • 19 slides

How to best treat cN1 prostate cancer? Karim Fizazi Institut Gustave Roussy France Disclosure

How to best treat cN1 prostate cancer? Karim Fizazi Institut Gustave Roussy France Disclosure Participation to advisory boards/honorarium for: Astellas, AAA, Bayer, Curevac, Janssen, MSD, Orion, Sanofi Randomized controlled trials in

208 views • 18 slides

How I (We) Treat CTCL Youn H Kim, MD Multidisciplinary Cutaneous Lymphoma Group Stanford Cancer

How I (We) Treat CTCL Youn H Kim, MD Multidisciplinary Cutaneous Lymphoma Group Stanford Cancer institute School University School of Medicine NCCN NHL Disclosures of Youn Kim TCL member Company Research Speakers Advisory Employee

1.99k views • 52 slides

A Cancer Immunotherapy Company Harnessing the Human Immune System To Diagnose and Treat Cancer

A Cancer Immunotherapy Company Harnessing the Human Immune System To Diagnose and Treat Cancer January 2015 January 2015 1 Disclaimer Disclaimer Forward Looking Statements THIS PRESENTATION CONTAINS FORWARD LOOKING STATEMENTS AND

329 views • 28 slides

A Cancer Immunotherapy Company Focused On The Development of

A Cancer Immunotherapy Company Focused On The Development of Vaccines And An<bodies to Diagnose and Treat Cancer Rodman & Renshaw 16 th Annual

689 views • 19 slides

How I treat high-risk MDS Matteo G Della Porta Cancer Center IRCCS Humanitas Research Hospital

How I treat high-risk MDS Matteo G Della Porta Cancer Center IRCCS Humanitas Research Hospital & Humanitas University Milano, Italy matteo.della_porta@hunimed.eu Clinical decision making in MDS - Critical issues How we can define

540 views • 22 slides

Finite Element Modeling of the TREAT (as Built) Reactor and a Possible 20% Enriched Fuel TREAT

Finite Element Modeling of the TREAT (as Built) Reactor and a Possible 20% Enriched Fuel TREAT PATRICK MCDANIEL NIMA FATHI CASSIANO DE OLIVEIRA TREAT Modeling The Treat reactor was built in 1959 to test fuel for fast reactors It operated

657 views • 17 slides

2/13/14 How I Treat Oral Chronic Graft-vs-Host Disease Nathaniel S. Treister, DMD, DMSc

2/13/14 How I Treat Oral Chronic Graft-vs-Host Disease Nathaniel S. Treister, DMD, DMSc Associate Surgeon, Dana-Farber-Brigham & Womens Cancer Center Assistant Professor, Harvard School of Dental Medicine Boston, MA o No

492 views • 10 slides

1 | TREAT-NMD 17 th September 2020 AGENDA 1. Welcome and introduction from participants 2.

LGMD CORE DATASET PROJECT 1 ST MEETING 1 | TREAT-NMD 17 th September 2020 AGENDA 1. Welcome and introduction from participants 2. Housekeeping and ground-rules 3. TREAT-NMD and TGDOC overview 4. Introduction to TREAT-NMD LGMD Global

1.28k views • 48 slides

INFECTIONS IN KIDS TO TREAT OR NOT TO TREAT? I HAVE NOTHING TO DISCLOSE. Andi Marmor, MD, MSED

3/14/18 INFECTIONS IN KIDS TO TREAT OR NOT TO TREAT? I HAVE NOTHING TO DISCLOSE. Andi Marmor, MD, MSED Professor of Pediatrics University of California, San Francisco Zuckerberg San Francisco General Hospital Three Common Presentations Case

415 views • 14 slides

Pediatric Obesity: To Treat or Not To Treat? Jamie Jeffrey, MD, FAAP Medical Director

WVDA 4-29-2010 Pediatric Obesity: To Treat or Not To Treat? Jamie Jeffrey, MD, FAAP Medical Director HealthyKids Pediatric Weight Management Program & Childrens Medicine Center WVU Associate Clinical Professor Pediatrics Project

1.05k views • 35 slides

INFECTIONS IN KIDS Community Acquired PNA Pharyngitis TO TREAT OR NOT TO TREAT? RASH

3/20/2019 Three Common Presentations FEVER DIFFICULTY BREATHING Fever without a source (SBI) Pertussis Urinary Tract Infections INFECTIONS IN KIDS Community Acquired PNA Pharyngitis TO TREAT OR NOT TO TREAT? RASH

346 views • 13 slides

WVDA 4-29-2010 Pediatric Obesity: To Treat or Not To Treat? Jamie Jeffrey, MD, FAAP Medical

1.21k views • 70 slides

Settin ting th the S Sce cene Craig Campbell Joanne Bullivant TGDOC Chair TREAT-NMD SMA

Settin ting th the S Sce cene Craig Campbell Joanne Bullivant TGDOC Chair TREAT-NMD SMA Dataset Project Manager 2 | TREAT-NMD WE WELCOME TRE REAT AT-NMD SMA NMD SMA DA DATASE ASET W WORK RKSHOP December 2 ber 2019 3 | TREAT-NMD

1.48k views • 120 slides

Treat at Home Treat at Home (An Aging at Home Program) 1 Promoting mental health, one mind at a

Treat at Home Treat at Home (An Aging at Home Program) 1 Promoting mental health, one mind at a time Purpose Purpose To serve seniors in their homes who require assessment, clinical and i t li i l d supportive monitoring, intensive

629 views • 13 slides

New Era for the Treatment of Cancer and Genetic Diseases February 16, 2018 1 Gene Therapy

New Era for the Treatment of Cancer and Genetic Diseases February 16, 2018 1 Gene Therapy Initial Strategy: Transfer of genetic material into cells to treat inherited genetic diseases First successful trial in 1990 at the NIH for Severe

355 views • 6 slides

DID YOU KNOW. In Malaysia, colon cancer ranks as the 2nd commonest cancer. No. 1 cancer

DID YOU KNOW. In Malaysia, colon cancer ranks as the 2nd commonest cancer. No. 1 cancer killer among Malaysian men and the second among the women. Chinese have the highest incidence of colon cancer, followed by Malays and Indians.

765 views • 29 slides